MX9206790A - PROCESS AND COMPOSITION FOR THE DEVELOPMENT OF A CONTROLLED RELEASE DOSE FORM OF GEMFIBROZIL - Google Patents

PROCESS AND COMPOSITION FOR THE DEVELOPMENT OF A CONTROLLED RELEASE DOSE FORM OF GEMFIBROZIL

Info

Publication number
MX9206790A
MX9206790A MX9206790A MX9206790A MX9206790A MX 9206790 A MX9206790 A MX 9206790A MX 9206790 A MX9206790 A MX 9206790A MX 9206790 A MX9206790 A MX 9206790A MX 9206790 A MX9206790 A MX 9206790A
Authority
MX
Mexico
Prior art keywords
gemfibrozil
development
composition
controlled release
dose form
Prior art date
Application number
MX9206790A
Other languages
Spanish (es)
Inventor
Isaac Ghebre-Sellassie
Uma Iyer
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of MX9206790A publication Critical patent/MX9206790A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
MX9206790A 1991-11-26 1992-11-25 PROCESS AND COMPOSITION FOR THE DEVELOPMENT OF A CONTROLLED RELEASE DOSE FORM OF GEMFIBROZIL MX9206790A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79837591A 1991-11-26 1991-11-26

Publications (1)

Publication Number Publication Date
MX9206790A true MX9206790A (en) 1993-05-01

Family

ID=25173228

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9206790A MX9206790A (en) 1991-11-26 1992-11-25 PROCESS AND COMPOSITION FOR THE DEVELOPMENT OF A CONTROLLED RELEASE DOSE FORM OF GEMFIBROZIL

Country Status (5)

Country Link
EP (1) EP0614358A1 (en)
JP (1) JPH07503236A (en)
CA (1) CA2123677A1 (en)
MX (1) MX9206790A (en)
WO (1) WO1993010775A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2271865C (en) * 1996-11-15 2003-10-14 Ajinomoto Co., Inc. Tablet composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0297866A3 (en) * 1987-07-01 1989-12-13 The Boots Company PLC Therapeutic agents
US4927639A (en) * 1989-02-02 1990-05-22 Warner-Lambert Company Modified release gemfibrozil composition
US4925676A (en) * 1989-02-02 1990-05-15 Warner-Lambert Company Extended release gemfibrozil composition
US4973470A (en) * 1989-06-26 1990-11-27 Warner-Lambert Company Sustained release pharmaceutical compositions

Also Published As

Publication number Publication date
WO1993010775A1 (en) 1993-06-10
EP0614358A1 (en) 1994-09-14
CA2123677A1 (en) 1993-06-10
JPH07503236A (en) 1995-04-06

Similar Documents

Publication Publication Date Title
NO20053106L (en) Oral, extended-release analgesic dosage form.
NO306446B1 (en) Oral pharmaceutical preparation comprising tramadol with controlled release effect
AR230186A1 (en) METHOD FOR THE TREATMENT OF A COMPOSITION INCLUDING FACTOR VIII
MX9204268A (en) A COMPOSITION FOR THE PROLONGED AND CONTROLLED RELEASE OF MEDICINAL SUBSTANCES AND A PROCESS TO PREPARE THE SAME.
NO912607L (en) FIXED, ORAL, PHARMACEUTICAL DOSAGE FORM WITH PROGRAMMED RELEASE
MX9203560A (en) A DOSAGE FORM TO GIVE PSEUDOEFEDRINA.
MX161165A (en) PROCEDURE FOR PREPARING A PROLONGED RELEASE PHARMACEUTICAL COMPOSITION
FR2514642B1 (en) DELAYED RELEASE PHARMACEUTICAL COMPOSITIONS
IT8867302A0 (en) DOSAGE FORM FOR CONTINUOUS RELEASE OF SIMILAR PHARMACEUTICAL SUBSTANCES
BR1100658A (en) Heterocyclic compound, pharmaceutical composition in unit dosage form, and process for the preparation of a heterocyclic compound
BE883779A (en) SPREAD RELEASE THERAPEUTIC COMPOSITIONS
LU90334I2 (en) Raloxifene and its pharmaceutically acceptable salts and derivatives
BR9203769A (en) GRANULAR DETERGENT COMPOSITION AND PROCESS FOR THE PREPARATION OF THE SAME
PT86986A (en) SUBSTITUTED 9-AMINO-TETRAHYDROACRIDINES AND RELATED COMPOUNDS A PROCESS FOR THEIR PREPARATION AND THEIR USE THE MEDICINES
DE69217288T8 (en) Diclofenac sodium plaster
ES508185A0 (en) A PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION IN THE FORM OF A MITARIC DOSE.
PT91003A (en) PROCESS FOR THE PREPARATION OF A NEW PHARMACEUTICAL FORM OF PROLONGED LIBERATION ON THE BASIS OF A RESIN COMPLEX-ACTIVE INGREDIENT
NO153396C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF A PHARMACOLOGICALLY ACCEPTABLE POLYMARY AGENT THAT CAN RELEASE A THERAPEUTIC EFFECTIVE COMPOUND.
MX174157B (en) DOSAGE FORM TO SUPPLY DILTIAZEN
ES523463A0 (en) A PROCEDURE FOR PREPARING A SLOW RELEASE PERFUME COMPOSITION
PT90104B (en) A process for the preparation of a solid, rapidly disintegrating, dosage form containing diclofenac
AR008176A1 (en) ORAL DOSAGE FORM OF CONTROLLED RELEASE AND USE OF THE SAME FOR THE MANUFACTURE OF MEDICINES
NO993627D0 (en) Use of a compound for the manufacture of a medicament
MX9206790A (en) PROCESS AND COMPOSITION FOR THE DEVELOPMENT OF A CONTROLLED RELEASE DOSE FORM OF GEMFIBROZIL
MX9200874A (en) COMPOUNDS OF A SPECIFIC COMPOSITION, A PROCEDURE FOR ITS PRODUCTION AND USE.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees